((2R,3R,4R)-3-((4-Chlorobenzoyl)oxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl 4-chlorobenzoate (CAS No: 1294481-79-0) is a key pharmaceutical intermediate used in the synthesis of APIs Sofosbuvir. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid gamama-lactone 3,5-bis(4-chlorobenzoate),3,5-Di-O-p-chlorobenzoyl-2-deoxy-2-fluoro-2-C-methyl-D-ribofurano-1,4-lactone
CAS No: 1294481-79-0
PubChem CID: 53304767
Mol Formula: C20H15Cl2FO6
Mol Weight: 441.2 g/mol
Used in API: Sofosbuvir
IUPAC Name: [(2R,3R,4R)-3-(4-chlorobenzoyl)oxy-4-fluoro-4-methyl-5-oxooxolan-2-yl]methyl 4-chlorobenzoate
API Intermediate Description: ((2R,3R,4R)-3-((4-Chlorobenzoyl)oxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl 4-chlorobenzoate is a highly functionalized, chiral fluorinated lactone derivative designed as a synthetic intermediate, not a finished drug and not an API by any regulatory definition.
